GLPwatch

Enteroendocrine cell regulation of the gut-brain axis.

Front Neurosci · 2023

Last updated 2026-05-28

Enteroendocrine cells (EECs) are hormone-producing cells in the gut that send signals to the brain about nutrients, pain, and even gut bacteria. Some EECs, called neuropod cells, communicate directly with nerves connected to the brain. Drugs like semaglutide (Ozempic, Wegovy) and terzepatide (Mounjaro) work by targeting these cells to help control blood sugar and weight.

AI summary of the abstract below.

JournalFront Neurosci, 2023
Citations47
Relative citation ratio6.58
NIH percentile95
Molecules

Abstract

Enteroendocrine cells (EECs) are an essential interface between the gut and brain that communicate signals about nutrients, pain, and even information from our microbiome. EECs are hormone-producing cells expressed throughout the gastrointestinal epithelium and have been leveraged by pharmaceuticals like semaglutide (Ozempic, Wegovy), terzepatide (Mounjaro), and retatrutide (Phase 2) for diabetes and weight control, and linaclotide (Linzess) to treat irritable bowel syndrome (IBS) and visceral pain. This review focuses on role of intestinal EECs to communicate signals from the gut lumen to the brain. Canonically, EECs communicate information about the intestinal environment through a variety of hormones, dividing EECs into separate classes based on the hormone each cell type secretes. Recent studies have revealed more diverse hormone profiles and communication modalities for EECs including direct synaptic communication with peripheral neurons. EECs known as neuropod cells rapidly relay signals from gut to brain via a direct communication with vagal and primary sensory neurons. Further, this review discusses the complex information processing machinery within EECs, including receptors that transduce intraluminal signals and the ion channel complement that govern initiation and propagation of these signals. Deeper understanding of EEC physiology is necessary to safely treat devastating and pervasive conditions like irritable bowel syndrome and obesity.

Verbatim abstract via PubMed 38027512 ↗